Literature DB >> 2433692

Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A.

J E Krause, J M Chirgwin, M S Carter, Z S Xu, A D Hershey.   

Abstract

Synthetic oligonucleotides were used to screen a rat striatal cDNA library for sequences corresponding to the tachykinin peptides substance P and neurokinin A. The cDNA library was constructed from RNA isolated from the rostral portion of the rat corpus striatum, the site of striatonigral cell bodies. Two types of cDNAs were isolated and defined by restriction enzyme analysis and DNA sequencing to encode both substance P and neurokinin A. The two predicted preprotachykinin protein precursors (130 and 115 amino acids in length) differ from each other by a pentadecapeptide sequence between the two tachykinin sequences, and both precursors possess appropriate processing signals for substance P and neurokinin A production. The presence of a third preprotachykinin mRNA of minor abundance in rat striatum was established by S1 nuclease protection experiments. This mRNA encodes a preprotachykinin of 112 amino acids containing substance P but not neurokinin A. These three mRNAs are derived from one rat gene as a result of differential RNA processing; thus, this RNA processing pattern further increases the diversity of products that can be generated from the preprotachykinin gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433692      PMCID: PMC304320          DOI: 10.1073/pnas.84.3.881

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

2.  A new glycopeptide in pig, ox and sheep pituitary.

Authors:  D G Smyth; D E Massey
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 4.  Substance P as a transmitter candidate.

Authors:  R A Nicoll; C Schenker; S E Leeman
Journal:  Annu Rev Neurosci       Date:  1980       Impact factor: 12.449

5.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

6.  Mechanism of C-terminal amide formation by pituitary enzymes.

Authors:  A F Bradbury; M D Finnie; D G Smyth
Journal:  Nature       Date:  1982-08-12       Impact factor: 49.962

7.  Transformation of E. coli using homopolymer-linked plasmid chimeras.

Authors:  S L Peacock; C M McIver; J J Monahan
Journal:  Biochim Biophys Acta       Date:  1981-09-28

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  66 in total

1.  Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.

Authors:  J A Bibb; Z Yan; P Svenningsson; G L Snyder; V A Pieribone; A Horiuchi; A C Nairn; A Messer; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors.

Authors:  L Tremblay; M L Kemel; M Desban; C Gauchy; J Glowinski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 3.  Role of substance P in inflammatory arthritis.

Authors:  N E Garrett; P I Mapp; S C Cruwys; B L Kidd; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

Review 4.  Tachykinins and excitotoxicity in cerebellar granule cells.

Authors:  Cinzia Severini; Cristina Zona
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

Review 5.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

6.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

7.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

8.  Tachykinins as mediators of slow EPSPs in guinea-pig gall-bladder ganglia: involvement of neurokinin-3 receptors.

Authors:  G M Mawe
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

9.  Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.

Authors:  T J Feuerstein; O Gleichauf; G B Landwehrmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

10.  Expression of neuropeptides and neuropeptide mRNAs in spinal cord after axotomy in the rat, with special reference to motoneurons and galanin.

Authors:  X Zhang; V M Verge; Z Wiesenfeld-Hallin; F Piehl; T Hökfelt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.